Browsing: Wegovy
Jacob Grönholt-Pedersen and Bhanvi Satija COPENHAGEN (Reuters) – Novo Nordisk’s (NYSE:) popular obesity drug Wegovy…
(Reuters) – The U.S. Senate Health, Education, Labor and Pensions Committee said on Friday that…
Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:) faces the prospect of increased competition in…
Maggie Fick LONDON (Reuters) – Novo Nordisk’s (NYSE:) obesity drug Wegovy reduced kidney-related adverse events…
Traditional medical practices are getting a boost from newcomers looking to fill gaps in what…
Regulators in Europe have found no evidence that popular diabetes and weight-loss drugs such as…